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Editor's Choice 
This issue opens with two complementary studies by medicaI students looking at sensory of 
the foot and the development of plantar u1cers. Mitchell tested healthy skin adjacent to u1cers 
to determine the leveI of protective sensation. In this small study, being able to perceive the 
10 g monofilament protected against the development of ulceration whereas perception of a 
30 g monofilament did not give protection. Feenstra et aI. tested a larger Ethiopian group all 
of whom were unable to detect the 10  g monofilament. In this group, the 10 g monofilament 
was the most sensitive test, but on1y 43% of feet with this leveI of sensory loss deve10ped 
u1cers. Other tests such as vibrometry or exarnination of functional anatomy were not more 
sensitive. The encouraging implication of this finding is that patients can protect their feet and 
stop u1ceration. We shall soon be reporting the findings of the self care groups in Ethiopia, 
this being one social intervention aimed at reducing u1ceration. 
Meima et aI. report on the dynamics of impairment. They have used the Eye-Hand-Foot 
scores to track the disability leveI of a cohort of patients. Being impaired at entry was the 
most important predictor of future impairment. In this cohort of the MB patients 56% had 
impairments at the start of their treatment and 43% improved or recovered whilst 1 3% 
worsened and 2 1  % o f  those without impairments worsened at re1ease from treatment. The 
post treatment follow-up was on1y 24-48 months but this and the succeeding years may be 
critically important, patients may still experience late reactions and they may deteriorate with 
secondary impairments (u1cers and tissue loss) .  Planning and funding services for these 
treated patients is a major challenge now. 
Margaret Hogeweg, in her editorial on blindness in leprosy, highlights the importance of 
cataract and the importance of ensuring that patients are screened and referred for cataract 
surgery. There should be no barriers for ex-Ieprosy patients to receiving surgery. 
After the special issue on the Leprosy Elimination campaigns [Lepr Rev 70(4) Dec 1999] , 
it is good to have some follow-up. One worry about the LECS was that the treatment 
completion rates would be low as the campaign enthusiasm waned. Fortunately this has not 
happened in Nigeria where the completion rates have been 96%, an astounding result 
anywhere. Defaulters remain a problem in Mozambique, as detailed by Griffiths and Ready, 
where the leprosy control programme is being rebuilt after the unrest. In 1 993, 60% patients 
were defaulting, although this has now fallen to 23% defaulters tend to default early. Thus 
early defaulters should be focussed on rather than hoping that they will return later. 
The M. leprae genome has now been published and to celebrate this we shall be devoting 
the December 2001 issue to exploring the genome and looking at the possibilities this offers 
to leprosy research and controI. 
Diana NJ Lockwood 
137 
